Additionally, studies suggested that therapies enhancing regulatory T cells (Tregs) function, such as expanded autologous Tregs with IL-2 and low-dose IL-2 itself, may slow ALS progression safely (23, 24). Here, IL2 is linked to amyotrophic lateral sclerosis.